Skip to main content
. 2024 Mar 13;57(3):242–251. doi: 10.5090/jcs.23.143

Table 3.

Clinical outcomes in mechanical AVR versus bioprosthetic AVR for patients aged 50 to 70 years (n=1,580)

Outcomesa) Original IPTW


No. of events (rate) OR or HR (95% CI) p-value No. of events (rate) OR or HR/sHR (95% CI) p-value


Mechanical AVR (N=984) Bioprosthetic AVR (N=596) Mechanical AVR (N=984) Bioprosthetic AVR (N=596)
Early outcomes, no. (%)
Early death 9 (0.9) 10 (1.7) 1.85 (0.75–4.58) 0.177 1.0 1.1 1.19 (0.42–3.33) 0.741
Bleeding requiring exploration 35 (3.6) 27 (4.5) 1.29 (0.77–2.15) 0.330 3.7 3.8 1.05 (0.60–1.83) 0.856
LCOS requiring MCSb) 11 (1.1) 11 (1.8) 1.66 (0.72–3.86) 0.230 1.1 1.2 1.08 (0.40–2.87) 0.885
Stroke 25 (2.5) 22 (3.7) 1.47 (0.82–2.63) 0.190 2.7 2.7 1.01 (0.53–1.95) 0.966
New onset dialysis 10 (1.0) 6 (1.0) 0.99 (0.36–2.74) 0.985 1.3 0.6 0.48 (0.15–1.59) 0.233
Sternal wound infection 12 (1.2) 8 (1.3) 1.10 (0.45–2.71) 0.830 1.2 1.3 1.14 (0.45–2.90) 0.787
Overall outcomes, no. (%/PY)
All-cause death 220 (2.0) 167 (3.6) 2.15 (1.74–2.64) <0.001 2.3 2.9 1.39 (1.07–1.80) 0.014
Stroke 106 (1.3) 32 (0.9) 0.63 (0.43–0.94) 0.025 1.4 0.5 0.44 (0.28–0.67) <0.001
Anticoagulation-related bleeding 119 (1.5) 31 (0.8) 0.55 (0.37–0.82) 0.004 1.5 0.6 0.35 (0.23–0.53) <0.001
Operated valve endocarditis 22 (0.3) 14 (0.4) 1.28 (0.66–2.53) 0.464 0.2 0.4 1.31 (0.61–2.82) 0.486
AV reintervention 41 (0.5) 35 (0.9) 2.35 (1.48–3.74) <0.001 0.4 0.8 6.14 (3.17–11.93) <0.001
SVD 0 17 (0.5) 0.0 0.4
Endocarditis 16 (0.2) 13 (0.3) 0.2 0.3
Pannus 15 (0.2) 1 (0.0) 0.2 0.0
Others 10 (0.1) 4 (0.1) 0.1 0.1
Readmission due to cardiac cause 256 (3.6) 118 (3.5) 0.96 (0.77–1.20) 0.710 3.6 3.1 1.30 (0.86–1.97) 0.210

Values are presented as number (%) or number (% per patient-year) unless otherwise indicated. Early outcomes are presented as ORs. Overall outcomes are presented as HRs or sHRs.

AVR, aortic valve replacement; IPTW, inverse-probability-of-treatment weighting; OR, odds ratio; HR, hazard ratio; CI, confidence interval; sHR, sub-distributional hazard ratio; LCOS, low cardiac output syndrome; MCS, mechanical circulatory support; PY, patient-year; AV, aortic valve; SVD, structural valve deterioration.

a)Outcomes captured using the primary diagnosis during a visit to the emergency department or using any primary or secondary diagnosis during hospitalization. b)Included extracorporeal membrane oxygenation, intra-aortic balloon pump, and ventricular assist device.